Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England
- PMID: 36074469
- PMCID: PMC9459656
- DOI: 10.1001/jamanetworkopen.2022.33446
Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England
Erratum in
-
Error in Table.JAMA Netw Open. 2022 Sep 1;5(9):e2238101. doi: 10.1001/jamanetworkopen.2022.38101. JAMA Netw Open. 2022. PMID: 36173638 Free PMC article. No abstract available.
Abstract
This cohort study of adults in England evaluates the association of sociodemographic and clinical risk factors with death from COVID-19 among individuals who completed primary vaccination and received a messenger RNA (mRNA) booster.
Conflict of interest statement
Figures

References
-
- Grange Z, Buelo A, Sullivan C, Moore E, Agrawal U, Boukhari K, McLaughlan I, Stockton D, McCowan C, Robertson C, Sheikh A, Murray JLK. Characteristics and risk of COVID-19–related death in fully vaccinated people in Scotland. Lancet. 2021;398(10313):1799-1800. doi:10.1016/S0140-6736(21)02316-3 - DOI - PMC - PubMed
-
- Agrawal U, Katikireddi SV, McCowan C, et al. . COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2.57 million people in Scotland (EAVE II): a prospective cohort study. Lancet Respir Med. 2021.;9(12):1439-1449. doi:10.1016/S2213-2600(21)00380-5 - DOI - PMC - PubMed
-
- Bosworth ML, Ahmed T, Larsen T, et al. . Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine roll-out: a retrospective, population-based cohort study. medRxiv. Preprint posted online February 15, 2022. doi:10.1101/2022.02.14.22270940 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical